The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Logan Carolyn J since 2006.
The trader's CIK number is 1212670.
At the time of the last reporting, Logan Carolyn J was the President & CEO of Salix Pharmaceuticals Ltd. (stock ticker symbol SLXP).
Also see all insider trading activities at Salix Pharmaceuticals Ltd.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | SLXP | 0 | $0 | 53,057 | $6,532,749 | 143,375 | $2,650,926 |
| 2012 | SLXP | 0 | $0 | 144,300 | $7,268,506 | 318,751 | $1,416,453 |
| 2010 | SLXP | 0 | $0 | 14,000 | $592,858 | 75,000 | $84,748 |
| 2009 | SLXP | 0 | $0 | 10,000 | $206,740 | 45,000 | $50,848 |
| 2007 | SLXP | 7,000 | $73,360 | 5,710 | $70,290 | 30,000 | $0 |
| 2006 | SLXP | 7,500 | $99,232 | 0 | $0 | 30,000 | $33,900 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-12-22 | SLXP | Option Ex | 44,000 | 17.63 | 775,720 |
| 2014-06-26 | SLXP | Option Ex | 99,375 | 18.87 | 1,875,206 |
| 2014-06-26 | SLXP | Sale | 53,057 | 123.13 | 6,532,749 |
| 2012-12-20 | SLXP | Option Ex | 33,750 | 7.60 | 256,500 |
| 2012-12-20 | SLXP | Sale | 25,000 | 42.27 | 1,056,675 |
| 2012-06-28 | SLXP | Option Ex | 228,467 | 4.07 | 929,860 |
| 2012-06-28 | SLXP | Sale | 119,300 | 52.07 | 6,211,831 |
| 2012-06-14 | SLXP | Option Ex | 36,534 | 4.07 | 148,693 |
| 2012-04-13 | SLXP | Option Ex | 20,000 | 4.07 | 81,400 |
| 2010-09-21 | SLXP | Sale | 14,000 | 42.35 | 592,858 |
| 2010-05-10 | SLXP | Option Ex | 40,000 | 1.13 | 45,199 |
| 2010-02-19 | SLXP | Option Ex | 35,000 | 1.13 | 39,549 |
| 2009-12-10 | SLXP | Option Ex | 35,000 | 1.13 | 39,549 |
| 2009-09-14 | SLXP | Option Ex | 10,000 | 1.13 | 11,299 |
| 2009-09-14 | SLXP | Sale | 10,000 | 20.67 | 206,740 |
| 2007-11-16 | SLXP | Buy | 7,000 | 10.48 | 73,360 |
| 2007-07-23 | SLXP | Option Ex | 30,000 | .00 | 0 |
| 2007-07-03 | SLXP | Sale | 5,710 | 12.31 | 70,290 |
| 2006-05-09 | SLXP | Buy | 7,500 | 13.23 | 99,232 |
| 2006-03-09 | SLXP | Option Ex | 30,000 | 1.13 | 33,900 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Logan Carolyn J (President & CEO of Salix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.